Literature DB >> 3092267

Associations among dexamethasone non-suppression and TRH-induced hormonal responses: increased specificity for melancholia?

C M Banki, M Arato, Z Papp, Z Rihmer, Z Kovacs.   

Abstract

TRH-induced thyrotropin (TSH), prolactin (PRL), and growth hormone (GH) responses were investigated together with a dexamethasone suppression test in female psychiatric inpatients with major melancholic depression (n = 21), schizophrenic disorder (n = 20), alcohol dependence (n = 11), and adjustment disorder with predominantly depressed mood (n = 13), as well as in 15 healthy women. Abnormal responses for all four endocrine variables were noted most frequently in melancholia; however, a significant number of the non-depressed patients also had abnormal hormonal responses in the individual test. The association of two or three abnormalities proved to be quite specific for the melancholic group. There were no statistically significant differences in TRH-induced TSH responses among the patient subgroups. Non-suppression of cortisol after dexamethasone was associated with blunted TSH-responses only in melancholia. There was a tendency for non-suppressor schizophrenics to show more abnormal GH-responses to TRH administration.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3092267     DOI: 10.1016/0306-4530(86)90055-7

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  3 in total

Review 1.  FLT3 inhibitors in acute myeloid leukemia: ten frequently asked questions.

Authors:  Ahmad I Antar; Zaher K Otrock; Elias Jabbour; Mohamad Mohty; Ali Bazarbachi
Journal:  Leukemia       Date:  2020-01-09       Impact factor: 11.528

2.  The effect of allostatic load on hypothalamic-pituitary-interrenal (HPI) axis before and after secondary vaccination in Atlantic salmon postsmolts (Salmo salar L.).

Authors:  Martin H Iversen; Robert A Eliassen
Journal:  Fish Physiol Biochem       Date:  2013-09-18       Impact factor: 2.794

3.  A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism.

Authors:  H Y Chan; C J Chang; S C Chiang; J J Chen; C H Chen; H J Sun; H G Hwu; M S Lai
Journal:  J Psychopharmacol       Date:  2008-09-18       Impact factor: 4.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.